Compared with HCC-Mock’ cells, HCC-shTGM2 cells displayed less invasion and resistance to cisplatin (although not statistically significant), showing increased E-cadherin expression and reduced vimentin expression, (Fig. 4a–c). This evidence concerns the gene VIM and hepatocellular carcinoma.